Table 2

Change in UCSS symptom scores from baseline, and response and remission rates during treatment in the two groups

IFN-β-1a (n=10)Placebo (n=7)p Value
IFN, interferon; UCSS, ulcerative colitis scoring system; PGA, physician’s global assessment.
Stool frequency−1.0 (1.2)−0.14 (0.89)NS
Rectal bleeding−0.4 (1.1)−0.42 (0.79)NS
PGA−0.56 (1.2)−0.38 (0.92)NS
Proctosigmoidoscopy score−0.8 (1.1) 0.14 (0.69)NS
Clinical response 5 (50%) 1 (15%)0.14
Remission 3 (30%) 0 (0%)0.02